APA

Fleischmann R. M., Alten R., Pileckyte M., Lobello K., Hua S. Y., Cronenberger C., Alvarez D., Bock A. E. & Sewell K. L. (20190514). A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis. : Arthritis research & therapy.

Chicago

Fleischmann Roy M, Alten Rieke, Pileckyte Margarita, Lobello Kasia, Hua Steven Y, Cronenberger Carol, Alvarez Daniel, Bock Amy E and Sewell K Lea. 20190514. A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis. : Arthritis research & therapy.

Harvard

Fleischmann R. M., Alten R., Pileckyte M., Lobello K., Hua S. Y., Cronenberger C., Alvarez D., Bock A. E. and Sewell K. L. (20190514). A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis. : Arthritis research & therapy.

MLA

Fleischmann Roy M, Alten Rieke, Pileckyte Margarita, Lobello Kasia, Hua Steven Y, Cronenberger Carol, Alvarez Daniel, Bock Amy E and Sewell K Lea. A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis. : Arthritis research & therapy. 20190514.